Atypical Hemolytic–Uremic Syndrome
Mario Negri Institute for Pharmacological Research
Indexed incrossrefpubmed
Abstract
The hemolytic–uremic syndrome, which is characterized by nonimmune hemolytic anemia, thrombocytopenia, and renal impairment, occurs most frequently in young children. Most cases are secondary to infection with Escherichia coli O157:H7 and other Shiga-toxin–producing strains. However, approximately 10% of cases are atypical and not associated with infection. This article reviews current concepts about the pathobiology of atypical hemolytic–uremic syndrome and its diagnosis and management.
Citation impact
1,322
total citations
- FWCI
- 25.57
- Percentile
- 100%
- References
- 159
Citations per year
Authors
2Topics & keywords
Topics
Keywords
- Hemolytic anemia
- Shiga toxin
- Atypical hemolytic uremic syndrome
- Medicine
- Escherichia coli
- Immunology
- Microbiology
- Biology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.